Will Poulter discusses the Dopesick finale | EW.com
Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) - LaughingPlace.com
A story people need to know': behind a shocking TV series about the opioid crisis | US television | The Guardian
State attorneys general call Purdue Pharma settlement a 'slap in the face' for victims of opioid crisis - Good Morning America
NH opposes settlement with OxyContin maker | Courts | unionleader.com
Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says - CBS News
Purdue Pharma files for bankruptcy. Here's what it means
Sacklers agree to new $6bn Purdue US settlement over opioids
PBS NewsHour | Purdue Pharma family protected from lawsuits in settlement | Season 2023 | PBS
Purdue Pharma files for bankruptcy. Here's what it means
In never-before-seen video, Richard Sackler defends Purdue - STAT
What opioid victims told Sacklers when they got the chance | The Seattle Times
Dopesick Finale Serves Up (Some) Retribution, But Also Redemption
Opinion | The Four Ordinary People Who Took On Big Pharma - The New York Times
South Carolina files lawsuit against manufacturer of OxyContin - Purdue Pharma in worsening opioid crisis | News | postandcourier.com
Recap: Dopesick Episodes 8 “The People vs. Purdue Pharma” (Hulu) - LaughingPlace.com
South Carolina files lawsuit against manufacturer of OxyContin - Purdue Pharma in worsening opioid crisis | News | postandcourier.com
Opioid Training Used 'Deceptive' Salesmen Movie
US Supreme Court halts Purdue's $6 billion opioid pact, will hear appeal | Business News | ArcaMax Publishing
A story people need to know': behind a shocking TV series about the opioid crisis | US television | The Guardian
Purdue's Demise Could Be A New Beginning For The Pharmaceutical Industry | Health Affairs
Dopesick casts the Sacklers and Purdue Pharma as villains of the opioid crisis : NPR
Legal shield for Purdue Pharma owners is at heart of appeals
Every Time I Thought the Purdue Pharma OxyContin Story Was Over, I Was Wrong - The New York Times
